DL_color_screen.png
Danube Labs Call for Proposals - September 2022
Your research project translated into the medicines of tomorrow

CEBINA has partnered with Evotec, the industry-leading drug discovery and development company, to create Danube Labs, an initiative to accelerate academic research projects for new therapeutics to mature into projects ready for spin-out company formation, or out-licensing.

AdobeStock_324787465.jpeg

WHAT ARE WE LOOKING FOR

Innovative drug discovery projects from Universities and Research Institutes in Central and Eastern Europe

(stage of development: at least in vitro PoC, ideally in vivo PoC)

Projects with significant commercial potential and unmet medical need​

Intellectual Property

(either filed patents or potential for new IP)​

Collaborative team spirit​

WHO WE ARE

Danube Labs is a partnership between:

cebina_logo_1_white.png
Evotec_white transparent.png
CBC logo white.png

We provide funding to bridge the gap between academia and industry, translating academic research projects into focused drug discovery programs

HOW IT WORKS

  • Submit a 1-3 page overview of your project to us 

  • We will evaluate your project and for selected projects work with you to create a detailed acceleration project proposal

  • Project proposals will be reviewed by our Joint Steering Committee for Danube Labs awards (ca. 500k€)

  • For awarded projects research work will be carried out by you, Evotec and CEBINA to reach the planned milestones within 6 to 9 months

  • Projects that meet the defined milestones and success criteria will be commercialized either through spin-out company formation or out-licencing

Applications for this Call for Proposals are currently open (until the 14th October 2022):

Learn more about Danube Labs at: www.danubelabs.eu

For any further inquiry, contact us at info@danubelabs.eu